We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+25.38%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.38B
AUM Growth
+$420M
Cap. Flow
-$361M
Cap. Flow %
-8.24%
Top 10 Hldgs %
55.94%
Holding
134
New
17
Increased
28
Reduced
47
Closed
10

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$92.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$65.3M
3
TCOM icon
Trip.com Group
TCOM
+$53.1M
4
CARR icon
Carrier Global
CARR
+$51.2M
5
MTN icon
Vail Resorts
MTN
+$37.8M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$104M
2
WUBA
58.com Inc
WUBA
+$90.6M
3
SWKS icon
Skyworks Solutions
SWKS
+$86.9M
4
MRNA icon
Moderna
MRNA
+$82.4M
5
ZTO icon
ZTO Express
ZTO
+$73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.01%
2 Technology 21.97%
3 Industrials 16.54%
4 Communication Services 16.31%
5 Healthcare 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADPT icon
76
Adaptive Biotechnologies
ADPT
$3.97B
$2.37M 0.05%
48,890
+4,108
+9% +$150K
CAH icon
77
Cardinal Health
CAH
$55.5B
$2.33M 0.05%
+44,670
New +$2.3M
RVTY icon
78
Revvity
RVTY
$12.8B
$2.29M 0.05%
23,334
-3,484
-13% -$319K
OVID icon
79
Ovid Therapeutics
OVID
$482M
$2.22M 0.05%
301,589
-81,346
-21% -$380K
BCRX icon
80
BioCryst Pharmaceuticals
BCRX
$2.41B
$2.2M 0.05%
462,402
-308,984
-40% -$1.23M
SGMO
81
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.15M 0.05%
240,512
-5,328
-2% -$49.4K
RCUS icon
82
Arcus Biosciences
RCUS
$3.63B
$2.15M 0.05%
87,058
-16,682
-16% -$450K
ORTX
83
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.14M 0.05%
35,702
+21,819
+157% +$2M
CBMG
84
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$2.04M 0.05%
135,921
-415,598
-75% -$5.94M
FPRX
85
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2M 0.05%
327,414
+76,198
+30% +$314K
MRNA icon
86
Moderna
MRNA
$23.9B
$1.99M 0.05%
31,060
-1,504,855
-98% -$82.4M
AAPL icon
87
Apple
AAPL
$4.46T
$1.96M 0.04%
21,448
– –
ZYME icon
88
Zymeworks
ZYME
$1.72B
$1.89M 0.04%
52,327
– –
XLRN
89
DELISTED
Acceleron Pharma
XLRN
$1.89M 0.04%
19,800
-3,087
-13% -$298K
DNTH icon
90
Dianthus Therapeutics
DNTH
$5.98B
$1.81M 0.04%
15,091
-1,218
-7% -$172K
NTLA icon
91
Intellia Therapeutics
NTLA
$1.65B
$1.76M 0.04%
83,737
– –
DNLI icon
92
Denali Therapeutics
DNLI
$3.9B
$1.71M 0.04%
70,793
– –
CSCO icon
93
Cisco
CSCO
$486B
$1.67M 0.04%
35,700
– –
ORCL icon
94
Oracle
ORCL
$423B
$1.63M 0.04%
29,418
– –
PVLA
95
Palvella Therapeutics
PVLA
$2.27B
$1.58M 0.04%
6,360
+2,562
+67% +$599K
FULC icon
96
Fulcrum Therapeutics
FULC
$294M
$1.53M 0.03%
83,550
-11,983
-13% -$189K
BIO icon
97
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.39M 0.03%
3,068
-1,107
-27% -$489K
ALEC icon
98
Alector
ALEC
$193M
$1.38M 0.03%
56,240
– –
CNTG
99
DELISTED
Centogene N.V. Common Shares
CNTG
$1.35M 0.03%
+59,080
New +$1.11M
PRTA icon
100
Prothena Corp
PRTA
$447M
$1.34M 0.03%
128,223
– –
2 3
4
5 6

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Platinum Investment Management held 134 positions worth $4.38B, up 11% from $3.96B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Platinum Investment Management withdrew a net $361M in Q2 2020, closing 10 positions and reducing 47 holdings. Its most notable exit was CF Industries, an estimated $47.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Platinum Investment Management opened a new position in Carrier Global worth $61.3M.

  • Platinum Investment Management's largest Q2 2020 buy was Carrier Global: 2,757,549 shares worth $61.3M.
  • Platinum Investment Management added most to GE Aerospace in Q2 2020, an estimated $92.3M increase.
  • Platinum Investment Management's biggest Q2 2020 reduction was Alphabet (Google) Class A, cutting an estimated $104M.
  • Platinum Investment Management fully exited CF Industries in Q2 2020, selling an estimated $47.4M.
  • Platinum Investment Management's ten largest holdings make up 56% of its $4.38B portfolio in Q2 2020.
  • Platinum Investment Management opened 17 new positions and closed 10 in Q2 2020.
  • Platinum Investment Management's portfolio value rose 11% quarter-over-quarter to $4.38B.

Based on Platinum Investment Management's 13F filing for Q2 2020, filed 6 Aug 2020.